IMMUNIC, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Immunic, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Immunic, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $928K, a 50% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $928K -$927K -50% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.1M -$861K -44% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $1.3M -$253K -16.3% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $1.41M +$149K +11.8% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $1.86M +$1.11M +149% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $1.96M +$1.09M +124% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.55M +$604K +63.7% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $1.26M +$209K +19.8% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $745K -$420K -36.1% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $874K -$368K -29.6% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $948K +$47K +5.22% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $1.05M +$114K +12.1% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $1.17M +$169K +17% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $1.24M +$638K +106% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $901K +$268K +42.3% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $940K +$869K +1224% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $996K +$928K +1365% Jun 30, 2020 10-Q/A 2020-08-03
Q1 2020 $604K +$592K +4933% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $633K Dec 31, 2019 10-K 2021-02-26
Q3 2019 $71K Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $68K Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $12K Mar 31, 2019 10-Q 2019-04-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.